Next Article in Journal
Microbial Clearance of Refractory Mycobacterium avium Complex Pulmonary Disease During Pembrolizumab and Intensified Antimicrobial Therapy: A Case Report
Next Article in Special Issue
Disproportionality Analysis of Oral Toxicities Associated with PI3K/AKT/mTOR Pathway Inhibitors Using the FAERS Database
Previous Article in Journal
A Second Opportunity for the Peptide-Based Analogues with γ-Lactam at the P1 Position: Human Cathepsin S Inhibition
Previous Article in Special Issue
Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(10), 1463; https://doi.org/10.3390/ph18101463
Action Date Notes Link
article xml file uploaded 28 September 2025 15:44 CEST Original file -
article xml uploaded. 28 September 2025 15:44 CEST Update https://www.mdpi.com/1424-8247/18/10/1463/xml
article pdf uploaded. 28 September 2025 15:44 CEST Version of Record https://www.mdpi.com/1424-8247/18/10/1463/pdf
article supplementary file uploaded. 28 September 2025 15:44 CEST - https://www.mdpi.com/1424-8247/18/10/1463#supplementary
article html file updated 28 September 2025 15:45 CEST Original file https://www.mdpi.com/1424-8247/18/10/1463/html
Back to TopTop